Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bryan R.G. Williams
Cellular Retinoic Acid–Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma
Cancer Research
Cancer Research
Oncology
Related publications
P53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma
Cancer Research
Cancer Research
Oncology
Direct Channeling of Retinoic Acid Between Cellular Retinoic Acid-Binding Protein II and Retinoic Acid Receptor Sensitizes Mammary Carcinoma Cells to Retinoic Acid-Induced Growth Arrest
Molecular and Cellular Biology
Cell Biology
Molecular Biology
The Cellular Retinoic Acid Binding Protein I Is Dispensable.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Cellular Retinoic Acid Binding Protein and Breast Cancer
Liver-Specific Cytochrome P450 CYP2C22 Is a Direct Target of Retinoic Acid and a Retinoic Acid-Metabolizing Enzyme in Rat Liver
Journal of Lipid Research
Biochemistry
Endocrinology
Cell Biology
Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma
Oncotarget
Oncology
The RET Oncogene Is a Critical Component of Transcriptional Programs Associated With Retinoic Acid-Induced Differentiation in Neuroblastoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
ABCC4/MRP4: A MYCN-regulated Transporter and Potential Therapeutic Target in Neuroblastoma
Frontiers in Oncology
Cancer Research
Oncology
Nuclear Detection of Cellular Retinoic Acid Binding Proteins I and II With New Antibodies
Journal of Histochemistry and Cytochemistry
Anatomy
Histology